Pediatr. praxi. 2020;21(4):275-280 | DOI: 10.36290/ped.2020.056

Specific issues of influenza in children in the context of the COVID-19 season

MUDr. Zuzana Blechová, Ph.D.
Klinika infekčních nemocí 2. LF UK a Nemocnice Na Bulovce, Praha

The paediatric population is a typical source for the spread of influenza as well as other respiratory viruses in the population, including coronavirus, particularly in the case of mild or asymptomatic course. In predisposed at-risk individuals or in those aged two to five years old, however, it may become a life-threatening infection due to respiratory or neurological complications. Annual influenza vaccination is essential primary prophylaxis affecting the morbidity, complications, and mortality of this infection; still, it has been neglected in our country.

Keywords: influenza, children, risk factors, complications, pregnancy, vaccination.

Published: September 3, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Blechová Z. Specific issues of influenza in children in the context of the COVID-19 season. Pediatr. praxi. 2020;21(4):275-280. doi: 10.36290/ped.2020.056.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Iuliano AD, et al. Estimates of global seasonal influenza‑associated respiratory mortality: a modelling study. Lancet 2018 Mar 31; 391(10127): 1285-1300. Go to original source...
    2. https://intermountainhealthcare.org/blogs/topics/live‑well/2020/03/whats‑the‑difference‑between‑a-cold‑the‑flu‑and‑coronavirus/.
    3. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2018; 2: CD004879. doi: 10.1002/14651858.CD004879.pub5, 10.1002/14651858.CD004879.pub5. Go to original source... Go to PubMed...
    4. Ortiz JR, Neuzil KM, Shay DK, Rue TC, Neradilek MB, Zhou H, Seymour CW, Hooper LG, Cheng PY, Goss CH, Cooke CR. The burden of influenza‑associated critical illness hospitalizations. Crit Care Med. 2014 Nov; 42(11): 2325-2332. Go to original source...
    5. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect, DiS. 2012; 54(10): 1427-1436. Go to original source... Go to PubMed...
    6. Dawood FS, Fiore A, Kamimoto L, et al. Influenza‑associated pneumonia in children hospitalized with laboratory‑confirmed influenza, 2003-2008. Pediatr Infect Dis J. 2010; 29(7): 585-590. doi:10.1097/inf.0b013e3181d411c5. Go to original source... Go to PubMed...
    7. Lau CH, Springston EE, Sohn MW, et al. Hand hygiene instruction decreases illness‑related absenteeism in elementary schools: a prospective cohort study. BMC Pediatr. 2012; 12: 52. Go to original source... Go to PubMed...
    8. Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, Mills RG, Ward P. Oral oseltamivir treatment of influenza in children Pediatr Infect Dis J. 2001; 20(2): 127. Go to original source...
    9. Ampofo K, Bender J, Sheng X, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics. 2008; 122(2): 229-237. doi: 10.1542/peds.2007-3192. Go to original source... Go to PubMed...
    10. Siefkes H, Hamele M, Ampofo K, Poss WB. Risk factors for poor outcomes and therapeutic strategies for seasonal and pandemic influenza. J Pediatr Intensive Care. 2014; 3(4): 217-226. doi:10.3233/PIC-14104. Go to original source... Go to PubMed...
    11. Louie JK, Yang S, Samuel MC, Uyeki TM, Schechter R. Neuraminidase inhibitors for critically ill children with influenza., Pediatrics. 2013; Dec; 132(6): e1539-e1545. Epub 2013 Nov 25. Go to original source...
    12. Au Committee on infectious diseases. Recommendations for Prevention and Control of Influenza in Children, 2019-2020. Pediatrics. 2019; 144(4) Epub 2019 Sep 2. Go to original source... Go to PubMed...
    13. Petersen E, et al.Comparing SARS‑CoV-2 with SARS‑CoV and influenza pandemics The Lancet Infectious Diseases. Published Online July 03, 2020:https://doi.org/10.1016/S1473-3099(20)30484-9. Go to original source... Go to PubMed...
    14. Dbaibo, G, et al: Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons, The Pediatric Infectious Disease Journal: January 2020 - Volume 39 - Issue 1 - p e1-e10 doi: 10.1097/INF.0000000000002504. Go to original source... Go to PubMed...
    15. Flannery B, Reynolds SB, Blanton L, et al. Influenza vaccine effectiveness against pediatric deaths: 2010-2014. Pediatrics. 2017; 139: e20164244 Go to original source... Go to PubMed...
    16. Chung A, Perera R, Brueggemann AB, et al. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ. 2007; 335: 429. Go to original source...
    17. Ferdinands JM, Olsho LE, Agan AA, et al. Effectiveness of influenza vaccine against life‑threatening RT‑PCR‑confirmed influenza illness in US children, 2010-2012. J Infect, DiS. 2014; 210(5): 674-683. Go to original source... Go to PubMed...
    18. Thompson MG, Kwong JC, Regan AK, et al. Influenza Vaccine Effectiveness in Preventing Influenza‑associated Hospitalizations During Pregnancy: A Multi‑country Retrospective Test Negative Design Study, 2010-2016. Clin Infect, DiS. 2019; 68(9): 1444-1453. doi:10.1093/cid/ciy737. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.